Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Andrews

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Inflammatory Bowel Diseases|May 19, 2017
Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel DiseaseNienke Z Borren, Grace Conway, William Tan, et al.
Expert Opinion on Drug Safety|November 22, 2021
Evaluating patient and physician knowledge of risks and safe use of rivaroxaban: a survey across four countriesLaurie Zografos, Dan Wolin, Elizabeth Andrews, et al.
The Journal of Infectious Diseases|August 15, 2009
Concurrent human papillomavirus-associated tonsillar carcinoma in 2 couplesElizabeth Andrews, Carol Shores, D Neil Hayes, et al.
Archives of Dermatological Research|August 2, 2023
IL-12/23-targeting in seborrheic dermatitis patients leads to long-lasting responseSabrina Ghalili, Eden David, Benjamin Ungar, et al.
Virology Journal|August 21, 2010
Detection and quantitation of HPV in genital and oral tissues and fluids by real time PCRWilliam T Seaman, Elizabeth Andrews, Marion Couch, et al.
Plos One|November 27, 2019
Mortality, morbidity, and cardiac surgery in Injection Drug Use (IDU)-associated versus non-IDU infective endocarditis: The need to expand substance use disorder treatment and harm reduction servicesKinna Thakarar, Kristina E Rokas, F L Lucas, et al.
Drugs - Real World Outcomes|July 31, 2017
Evaluating the Safety of Medication Exposures During Pregnancy: A Case Study of Study Designs and Data Sources in Multiple SclerosisWhitney S Krueger, Mary S Anthony, Catherine W Saltus, et al.
Pharmaceutical Medicine|January 15, 2020
Physician and Patient Knowledge of Safety and Safe Use Information for Aflibercept in Europe: Evaluation of Risk-Minimization MeasuresLaurie J Zografos, Elizabeth Andrews, Daniel L Wolin, et al.
Plos One|November 29, 2023
Comparison of vaginal microbiota between women with inflammatory bowel disease and healthy controlsOfri Bar, Leanna S Sudhof, Laura J Yockey, et al.
Cephalalgia : an International Journal of Headache|August 1, 2017
Utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from an observational study in EuropeManjit Matharu, Julio Pascual, Ingela Nilsson Remahl, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Inflammatory Bowel Diseases|May 19, 2017
Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel DiseaseNienke Z Borren, Grace Conway, William Tan, et al.
Expert Opinion on Drug Safety|November 22, 2021
Evaluating patient and physician knowledge of risks and safe use of rivaroxaban: a survey across four countriesLaurie Zografos, Dan Wolin, Elizabeth Andrews, et al.
The Journal of Infectious Diseases|August 15, 2009
Concurrent human papillomavirus-associated tonsillar carcinoma in 2 couplesElizabeth Andrews, Carol Shores, D Neil Hayes, et al.
Archives of Dermatological Research|August 2, 2023
IL-12/23-targeting in seborrheic dermatitis patients leads to long-lasting responseSabrina Ghalili, Eden David, Benjamin Ungar, et al.
Virology Journal|August 21, 2010
Detection and quantitation of HPV in genital and oral tissues and fluids by real time PCRWilliam T Seaman, Elizabeth Andrews, Marion Couch, et al.
Plos One|November 27, 2019
Mortality, morbidity, and cardiac surgery in Injection Drug Use (IDU)-associated versus non-IDU infective endocarditis: The need to expand substance use disorder treatment and harm reduction servicesKinna Thakarar, Kristina E Rokas, F L Lucas, et al.
Drugs - Real World Outcomes|July 31, 2017
Evaluating the Safety of Medication Exposures During Pregnancy: A Case Study of Study Designs and Data Sources in Multiple SclerosisWhitney S Krueger, Mary S Anthony, Catherine W Saltus, et al.
Pharmaceutical Medicine|January 15, 2020
Physician and Patient Knowledge of Safety and Safe Use Information for Aflibercept in Europe: Evaluation of Risk-Minimization MeasuresLaurie J Zografos, Elizabeth Andrews, Daniel L Wolin, et al.
Plos One|November 29, 2023
Comparison of vaginal microbiota between women with inflammatory bowel disease and healthy controlsOfri Bar, Leanna S Sudhof, Laura J Yockey, et al.
Cephalalgia : an International Journal of Headache|August 1, 2017
Utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from an observational study in EuropeManjit Matharu, Julio Pascual, Ingela Nilsson Remahl, et al.
Pageof 7